Gadot looks to strengthen U.S. presence
August 09, 2007
by Eric Schroeder
HAIFA, ISRAEL — In an effort to strengthen its position in the U.S. market, Gadot Biochemical Industries, Ltd. (G.B.I.) announced it has reorganized its activities in the North American market following the acquisition of Pharmline, USA. Gadot, a supplier of crystalline fructose, citrate salts and enrichment minerals, said the move is in line with its strategy of focusing on the nutraceutical and functional food markets.
As part of the reorganization, Antony Hand, a former vice-president of marketing at Clearon, USA, was named president of Gadot Bio-Chem USA, Ltd. He will be responsible for the food industry in North America, specifically the functional food market.
Pharmline, acquired earlier this year, is a private company involved in the processing and marketing of ingredients and premixes to the nutraceuticals market in North America. Its headquarters and production site are located in Florida, N.Y.
Primarily active in the dietary supplements segment, Pharmline is expected to step up its presence in the health food market under Gadot’s leadership, the company said.
"Our strategy is to offer food and beverage producers an extensive line of functional ingredients and processing services through the Pharmline portfolio," said Ronny Hacham, vice-president of business development and marketing, Gadot. "These actions will help expand the company’s competitive edge in the functional foods market, and will shorten time-to-market while offering next-generation healthy ingredients."